Wilentin 250 mg, Hartkapseln

7680679000018 CH-67900 Kapseln
Wilentin 250 mg, Hartkapseln
Wilentin 250 mg, Hartkapseln
1 / 2
google

Article details

Package size
100
Selling units
100
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/09/2026
Patient information leaflet
Français
26/09/2026
Patient information leaflet
Italien
26/09/2026
Summary of Product Characteristics
Allemand
26/09/2026
Summary of Product Characteristics
Français
26/09/2026
Summary of Product Characteristics
Italien
26/09/2026

Detailed composition

Substance Quantity Type Category
trientini dihydrochloridum
250.0 MG Substance Wirkstoff (Principe actif)
acidum stearicum
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 110
0.44 MG Substance HBESI
aqua
- Substance HNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 2533.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2023

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
67900
Drug name
Wilentin, Hartkapseln
Galenic form
KAHA
ATC Code
A16AX12
Authorization status
Z
Dispensing category
B
First authorization
08/12/2021
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen

Package details

Description (FR)
WILENTIN caps 250 mg bte 100 pce
Description (DE)
WILENTIN Kaps 250 mg Ds 100 Stk
Market launch
08/12/2021
Narcotic (BTM)
No

Other package sizes (1)

WILENTIN caps 300 mg bte 100 pce
100 KAP
GTIN: 7680679000025
View
Buy us a coffee Explore the data